mahalie via Compfight cc
HRA Pharma head of women's health Frederique Welgryn told The
The new warning also says that the drug's efficacy is reduced in women who weigh more than 75 kilograms (165 pounds).
HRA markets Norlevo in about 50 countries worldwide. It began marketing the pill in France in 1999 and now sells about 1.5 million doses per year there. It will begin printing the warning on packaging in the first half of 2014.